Survive and Scale: 8 Critical SaaS Metrics for CEOs Leading <$20M SLG SaaS Companies
Discover the 11 critical SaaS metrics every CEO of a <$20M SLG SaaS company must master to survive and scale in 2025. Benchmark your growth and performance.
Discover the 11 critical SaaS metrics every CEO of a <$20M SLG SaaS company must master to survive and scale in 2025. Benchmark your growth and performance.
Carta’s Q1 2025 Pre‑Seed Report reveals key trends in deal volume, SAFE dominance, rising valuation caps, and regional funding shifts. Learn what it means for founders and investors.
Venture capital is recovering—but not for everyone. This post breaks down what seed-stage founders must know in H1 2025, from rising Series A benchmarks to the smart use of seed extensions and AI positioning.
Carta’s Q1 2025 private market data reveals a drop in seed funding and longer timelines to Series A. For pre-seed SaaS founders, the bar is higher—but the playbook is clearer. Here’s what you need to know.
This SEO + GEO optimized guide walks you through a 10-step GenAI workflow for B2B SaaS companies. Learn how to structure, prompt, and automate content for both search engines and AI-generated answer platforms.
Explore the Q1 2025 Crunchbase startup investment report through 11 powerful charts. Discover how late-stage and AI deals surged while early-stage funding declined globally. Key insights across North America, Asia, Europe, and Latin America—plus what’s ahead for early-stage founders.
The UK’s early-stage SaaS landscape is shifting rapidly. This 2000-word summary of PitchBook’s Q1 2025 UK Market Snapshot helps CEOs and board members understand critical trends across funding, exits, valuations, and macroeconomic factors.
MDAgent is transforming materials science by helping researchers automate molecular dynamics simulations. Discover how AI cuts simulation time by 42% and makes materials research faster, easier, and more accessible.
As startups stay private longer and venture returns are delayed, seed-stage investors are increasingly relying on secondary markets for early liquidity. This post explores the insights from Hunter Walk’s latest blog, showing why selling shares is now a strategic move—not a red flag—in modern venture capital.
Early-stage startup funding in Europe remained steady in Q1 2025 despite global volatility. This blog post breaks down investment trends across the UK, Germany, France, and Spain, highlights top sectors like biotech and AI, and explores why Europe’s startup ecosystem continues to thrive.